Human Papillomavirus, High Carcinogenic Risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), Digene Test

Detection of high-risk human papillomavirus in test samples - indicating a high risk of cancer (causes cancer of the cervix, rectum, penis, head, neck, and lungs); performed using the Digene HPV test - a highly sensitive test, modern molecular technology aimed at identifying specific fragments of human papillomavirus DNA (“hybrid capture” method). High-precision and modern laboratory analysis that reliably detects or excludes HPV. A single general result (positive/negative) for all listed types is provided with a semi-quantitative assessment, without differentiation by type.

Within 17 days. The specified time does not include the day of biomaterial collection